Home / Inspections / 1203119

FDA Inspection 1203119 — Keith E. Stockerl Goldstein, MD

Keith E. Stockerl Goldstein, MD — FEI 3025923694

The FDA completed an inspection of Keith E. Stockerl Goldstein, MD on March 31, 2023 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 31, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Saint Louis, MO (United States)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources